Nigeria faces a mounting hypertension emergency with over 41 million adults now living with the condition, as skyrocketing medication prices force patients into life-threatening “drug holidays.”
Experts warn the silent killer is driving an unprecedented spike in sudden deaths nationwide, with four in ten Nigerian adults affected but only 15% achieving proper blood pressure control.
The crisis has turned routine treatment into a financial nightmare.
Premium hypertension drugs like Novasc have jumped from ₦2,000 to ₦28,000 monthly, while generics now cost ₦5,000-₦15,000 – sums exceeding many Nigerians’ monthly food budgets. At Lagos pharmacies, patients like 52-year-old tailor Chinedu confess to rationing medications: “I either buy drugs or feed my family. Some months I just pray.”
Medical professionals report devastating consequences. “We’re seeing strokes and heart attacks in people under 30,” reveals Prof. Akin Osibogun of NCD Alliance Nigeria. The South-East records the highest prevalence (52.8%), with sudden deaths now so frequent that cardiologists suspect most are hypertension-related.
The root causes form a perfect storm:
- 70% of patients unaware of their condition until crisis strikes
- Local drug production crippled by imported ingredients and forex volatility
- National health insurance covers less than 10% of population
- Worsening salt addiction and sedentary lifestyles
Federal authorities claim tariff waivers will ease drug costs, but pharmacists report no price reductions. “Until we fix forex and local production, medications will remain unaffordable,” says Health Peak Pharma’s Amakeze Azubike.
With Nigeria’s under-40 population now experiencing hypertension-related deaths, the Nigerian Cardiac Society has launched emergency “Know Your Numbers” screenings in markets and banks.
As Prof. Augustine Odili warns: “This isn’t just a health crisis – it’s a national time bomb.”
